GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » EBITDA Margin %

Ajanta Pharma (BOM:532331) EBITDA Margin % : 29.77% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ajanta Pharma's EBITDA for the three months ended in Mar. 2024 was ₹3,138 Mil. Ajanta Pharma's Revenue for the three months ended in Mar. 2024 was ₹10,541 Mil. Therefore, Ajanta Pharma's EBITDA margin for the quarter that ended in Mar. 2024 was 29.77%.


Ajanta Pharma EBITDA Margin % Historical Data

The historical data trend for Ajanta Pharma's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma EBITDA Margin % Chart

Ajanta Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.12 36.01 31.82 23.56 29.86

Ajanta Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.11 29.68 30.34 29.65 29.77

Competitive Comparison of Ajanta Pharma's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Ajanta Pharma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ajanta Pharma's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ajanta Pharma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Ajanta Pharma's EBITDA Margin % falls into.



Ajanta Pharma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Ajanta Pharma's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=12565.4/42087.1
=29.86 %

Ajanta Pharma's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=3138.2/10540.8
=29.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ajanta Pharma  (BOM:532331) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Ajanta Pharma EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Ajanta Pharma's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ajanta Pharma (BOM:532331) Business Description

Traded in Other Exchanges
Address
Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067
Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma (BOM:532331) Headlines

No Headlines